Pd Tris(o-tolyl)phosphine Mono(amine) Complexes
Organometallics, Vol. 15, No. 12, 1996 2753
p-iodotoluene (0.6 g, 2.7 mmol) using a procedure analogous
to that used to prepare 4 led to the isolation of 5 (207 mg,
60%) as a pale orange powder which contained traces (<5%)
analogous to that used to generate 8-(CD3CN)2 formed 11-(CD3-
CN)2, which was analyzed without isolation by NMR. 1H NMR
(CD3CN, 50 °C): δ 7.64 (m), 7.49 (t, J ) 7.5 Hz), 7.28 (m),
6.75, 6.72, 6.67 (m), 2.16 [br s, 9 H, P(o-tol)3], 1.32 (s, 3 H,
C6H4CMe3). 31P{1H} NMR (CD3CN, 50 °C): δ 25.2.
1
of Et2O by H NMR analysis. 1H NMR (55 °C): δ 7.34, 7.07
(br), 6.73 (br), 6.32 (d, J ) 6.38 Hz), 2.11 [br, 9 H, P(o-tol)3],
1.98 (C6H4Me). 31P{1H} NMR: δ 25.5 (br). Anal. Calcd
(found) for C56H56I2P2Pd2: C, 53.48 (53.45); H, 4.49 (4.65); I,
20.18 (20.19).
P d [P (o-tol)3](p-C6H4Me)[HN(CH3)Bn ]Cl (12). N-Benzyl-
methylamine (263 mg, 2.2 mmol) was added to a yellow
solution of 9 (200 mg, 0.19 mmol) in 10 mL of C6H6 and stirred
at room temperature for 15 min, and the resulting clear
solution was allowed to stand at room temperature. A white
precipitate formed over 2 h, which was filtered, washed with
ether, and dried under vacuum to give 12 (207 mg, 85%) as a
white microcrystalline solid. 1H NMR (55 °C): δ 7.63 (br), 7.51
(d, J ) 3.4 Hz), 7.38 (m), 7.34, 7.29 (t, J ) 7.5 Hz), 7.09 (m),
6.36 (m), 4.39 [br t, J ) 12.4 Hz, 1 H, HN(CH3)CH2Ph], 3.47
[dt, J ) 12.5, 7 Hz, HN(CH3)CH2Ph], 3.22 [br s, 1 H, HN(CH3)-
Bn], 2.46 [d, J ) 6.0 Hz, 3 H, HN(CH3)Bn], 2.22 [br, 9 H, P(o-
tol)3], 2.03 (s, C6H4Me). 31P{1H} NMR: δ 27.9. IR (Nujol):
3261 cm-1. Anal. Calcd (found) for C36H39ClNPPd: C, 65.66
(65.92); H, 5.97 (6.07); N, 2.13 (2.10).
{P d [P (o-tol)3](p-C6H4OMe)(µ-I)}2 (6). Reaction of Pd2-
(DBA)3 (250 mg, 0.27 mmol), P(o-tol)3 (330 mg, 1.1 mmol), and
p-iodoanisole (900 mg, 3.8 mmol) using a procedure analogous
to that used to prepare 4 led to the isolation of 6 (180 mg,
51%) as a pale orange powder which contained traces (<5%)
of Et2O by 1H NMR analysis. 1H NMR (55 °C): δ 7.25 (m),
7.08 (br), 6.75 (br), 6.17 (d, J ) 7.46 Hz), 3.53 (s, 3 H,
C6H4OMe), 2.14 [br, 9 H, P(o-tol)3]. 31P{1H} NMR: δ 25 (br).
Anal. Calcd (found) for C56H56I2O2P2Pd2: C, 52.16 (52.01); H,
4.38 (4.54); I, 19.68 (19.97).
{P d [P (o-tol)3]I(µ-I)}2. A solution of PdI2 (200 mg, 0.55
mmol), LiI (162 mg, 1.21 mmol), and P(o-tol)3 (380 mg, 1.25
mmol) in MeOH (7 mL) was heated at reflux for 30 min. The
resulting brown suspension was cooled to room temperature,
filtered in air, washed with methanol (20 mL) and Et2O (20
mL), and dried under vacuum to give {Pd[P(o-tol)3]I2}2 (357
mg, 97%) as a dark brown powder. 1H NMR: δ 9.21, 7.47,
7.14, 3.26, 1.90, 1.55. 31P{1H} NMR: δ 30.6 (br). Anal. Calcd
(found) for C42H42I4P2Pd2: C, 37.95 (37.65); H, 3.26 (3.11); I,
38.19 (38.09).
P d [P (o-tol)3](p-C6H4Me)[HN(CH 3)Bn ]Br (13). N-Ben-
zylmethylamine (160 mg, 1.32 mmol) was added to a yellow
solution of 2 (150 mg, 0.13 mmol) in 5 mL of CH2Cl2 and stirred
at room temperature for 10 min. The resulting colorless
solution was concentrated to 1 mL under vacuum and diluted
with 20 mL of hexane. Cooling the solution via concentration
to 10 mL under vacuum formed a white precipitate, which was
filtered, washed with hexane, and dried under vacuum to give
13 (148 mg, 83%) as a pale yellow microcrystalline solid. 1H
NMR (55 °C): δ 7.84, 7.37, 7.29 (t, J ) 7 Hz), 7.10, 6.38, 4.40
[br s, 1 H, HN(CH3)CH2Ph], 4.35 [br s, 1 H, HN(CH3)Bn], 3.42
[br s, 1 H, HN(CH3)CH2Ph], 2.46 [br s, 3 H, HN(CH3)Bn], 2.18
[br, 9 H, P(o-tol)3], 2.05 (s, 3 H, C6H4Me). 31P{1H} NMR: δ
P d [P (o-tol)3]2Br 2 (7).9 Reaction of PdBr2 (200 mg, 0.75
mmol), LiBr (140 mg, 1.61 mmol), and P(o-tol)3 (514 mg, 1.70
mmol) using a procedure analogous to that used to prepare
{Pd[P(o-tol)3]I2}2 led to the isolation of 7 (623 mg, 100%) as
an orange powder. 1H NMR: δ 9.21, 8.85, 7.22, 7.10, 2.97 (br),
1.95 (br), 1.60. 31P{1H} NMR: δ 20.2, 19.4 (∼1:1).
27.9. IR (Nujol): 3257 cm-1. Anal. Calcd (found) for C36H39
BrNPPd: C, 61.51 (61.63); H, 5.59 (5.83); N, 1.99 (2.06).
-
{P d [P (o-tol)3](p-C6H4Me)[CD3CN]2}+OTf- (8-(CD3CN)2).
Silver triflate (3 mg, 1 × 10-2 mmol) was added to a suspension
of 5 (5 mg, 4 × 10-3 mmol) in CD3CN (0.75 mL), and the
mixture was shaken for 1 min. The resulting yellow solution
of 8-(CD3CN)2 was filtered into an NMR tube and analyzed
without isolation. 1H NMR (CD3CN, 75 °C): δ 7.68 (m), 7.48
(t, J ) 7.5 Hz), 7.33 (t, J ) 7.5 Hz), 7.28 (t, J ) 7.5 Hz), 6.56
(t, J ) 7.5 Hz), 2.34 [br s, 9 H, P(o-tol)3], 2.10 (s, 3 H, C6H4Me).
31P{1H} NMR (CD3CN, 50 °C): δ 25.2.
P d [P (o-tol)3](p-C6H4Me)[HN(CH3)Bn ]I (14). Reaction of
5 (220 mg, 0.18 mmol), and N-benzylmethylamine (212 mg,
1.75 mmol) using a procedure analogous to that used to
prepare 13 led to the isolation of 14 (186 mg, 71%) as a pale
yellow microcrystalline solid. 1H NMR (∼80:20 ratio of 14:5):
δ 7.37, 7.29, 7.05, 6.4, 4.48 [br, 1 H, HN(CH3)CH2Ph], 3.47
[br, 1 H, HN(CH3)CH2Ph], 3.22, [br, 6 H, P(o-tol)3], 2.48 [br, 3
H, HN(CH3)Bn], 2.04 (s, 3 H, C6H4Me), 1.50 [br s, 3 H, P(o-
tol)3], HN(CH3)Bn not observed. 31P{1H} NMR {CDCl3 [0.05
M HN(Me)Bn]}: δ 28.1. IR (Nujol): 3253 cm-1. Anal. Calcd
(found) for C36H39ClNPPd: C, 57.65 (57.53); H, 5.24 (5.48); N,
1.87 (2.14).
{P d [P (o-tol)3](p-C6H4Me)(µ-Cl)}2 (9). A suspension of 5
(220 mg, 0.17 mmol) and AgOTf (94 mg, 0.37 mmol) in 5 mL
of CH3CN was stirred at room temperature for 5 min. The
resulting yellow solution was decanted from the gray precipi-
tate, which was extracted with an additional 5 mL of CH3CN.
LiCl (500 mg, 12.7 mmol) was added to the combined extracts,
and the resulting suspension was stirred at room temperature
for 2 days. Acetonitrile was evaporated under vacuum, and
the residue was extracted with toluene and filtered through
Celite. Evaporation of toluene and addition of Et2O (5 mL)
gave a pale yellow solution. Dropwise addition of pentane (10
mL) formed a yellow precipitate, which was washed with Et2O
and pentane and dried under vacuum to give 9 (175 mg, 93%)
as a pale yellow powder. 1H NMR: δ 7.68 (br, 3 H), 7.27 (t, J
) 7.05 Hz, 3 H), 7.08 (m, 6 H), 6.48 (br, 2 H), 6.30 (d, J ) 7.72
Hz, 2 H), 2.22 [s, 9 H, P(o-tol)3], 1.98 (s, 3 H, C6H4Me). 31P-
{1H} NMR: δ 28.8. Anal. Calcd (found) for C56H56Cl2P2Pd2:
C, 62.59 (62.34); H, 5.25 (5.53); Cl, 6.60 (6.71).
{P d [P (o-tol)3](p-C6H4CMe3)(µ-Cl)}2 (10). Reaction of 1
(410 mg, 0.33 mmol) and AgOTf (169 mg, 0.66 mmol), followed
by treatment with LiCl (750 mg, 17.8 mmol) using a procedure
analogous to that used to prepare 9, led to the isolation of 10
(216 mg, 57%) as a yellow powder. 1H NMR (55 °C): δ 7.70
(br, 3 H), 7.25 (m, 3 H), 7.08 (br, 6 H), 6.59 (br), 6.47 (d, J )
7.76 Hz), 2.17 [br, 9 H, P(o-tol)3], 1.07 (C6H4CMe3). 31P{1H}
NMR: δ 28.2. Anal. Calcd (found) for C62H68Cl2P2Pd2: C,
64.26 (64.48); H, 5.91 (6.17); Cl, 6.12 (6.11).
P d[P (o-tol)3](p-C6H4OMe)[HN(CH3)Bn ]Br (15). A purple
solution of Pd2(DBA)3 (150 mg, 0.16 mmol), P(o-tol)3 (250 mg,
0.82 mmol), p-bromoanisole (313.1 mg, 1.6 mmol), and benzyl-
(methyl)amine (235 mg, 1.9 mmol) in 5 mL of benzene was
stirred at room temperature for 2 days. The resulting green-
brown suspension was filtered through Celite, and the residue
was extracted with CH2Cl2 (50 mL) and evaporated under
vacuum. Addition of Et2O (20 mL) to the resulting oily residue
formed a yellow precipitate, which was filtered, washed with
Et2O and pentane, and dried under vacuum to give 15 (120
mg, 51%) as a pale yellow powder. 1H NMR (C6D6, 75 °C): δ
7.80, 7.20, 7.05, 6.88, 6.36, 4.55 [br, HN(Me)CH2Ph], 3.50 [br,
HN(Me)CH2Ph], 3.29 (s, C6H4OMe), 3.18 [br, HN(Me)CH2Ph],
2.33 [br, P(o-tol)3], 2.25 [br, HN(Me)Bn]. 31P{1H} NMR: δ 27.9
(br). IR (Nujol): 3258 cm-1. Anal. Calcd (found) for C36H39
BrNOPPd: C, 60.14 (60.35); H, 5.47 (5.79); N, 1.95 (1.95).
-
P d [P (o-tol)3](p-C6H4Me)[H2NBn ]Cl (16). Reaction of 9
(150 mg, 0.14 mmol) and benzylamine (74 mg, 0.7 mmol) using
a procedure analogous to that used to prepare 13 led to the
isolation of 16 (127 mg, 70%) as a pale yellow microcrystalline
solid, which contained traces (e5%) of hexane by 1H NMR
analysis. 1H NMR (50 °C): δ 7.74 (br, 3 H), 7.28 (t, J ) 6.4
Hz, 3 H) 7.21 (m, 3 H), 7.11 (m, 7 H), 6.58 (br s, 2 H), 6.46 (d,
J ) 7.3 Hz, 2 H), 3.75 (br, 2 H, H2NCH2Ph), 2.91 (br, 2 H,
H2NCH2Ph), 2.21 [br s, 9 H, P(o-tol)3], 2.07 (s, 3 H, C6H4Me).
{P d [P (o-tol)3](p-C6H4CMe3)[CD3CN]2}+OTf- (11-(CD3-
CN)2). Reaction of silver triflate (5 mg, 2 × 10-2 mmol) and
1 (7 mg, 6 × 10-3 mmol) in CD3CN (0.80 mL) using a procedure